;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Dynavax financial update

    Dynavax Technologies Corp. (NASDAQ:DVAX), Berkeley, Calif. Business: Inflammation, Infectious, Autoimmune Date announced: 2014-11-10 Note: Dynavax filed a shelf registration covering the sale of up to $200 million of …

    Published on 11/17/2014
  • Evoke Pharma financial update

    Evoke Pharma Inc. (NASDAQ:EVOK), San Diego, Calif. Business: Gastrointestinal Date announced: 2014-11-13 Note: Evoke filed a shelf registration covering the sale of up to $100 million of its securities. The company, …

    Published on 11/17/2014
  • Five Prime financial update

    Five Prime Therapeutics Inc. (NASDAQ:FPRX), South San Francisco, Calif. Business: Cancer, Autoimmune, Inflammation Date announced: 2014-11-10 Note: Five Prime filed a shelf registration covering the sale of up to $100 …

    Published on 11/17/2014
  • Humorigin financial update

    Humorigin Biotechnology Corp. (GreTai-E:6487), New Taipei City, Taiwan Business: Antibodies, Supply/Service Date announced: 2014-11-10 Note: Humorigen began the formal process to list on the GreTai Securities Market in …

    Published on 11/17/2014
  • Immunovaccine financial update

    Immunovaccine Inc. (TSX-V:IMV), Halifax, Nova Scotia Business: Cancer, Infectious Date announced: 2014-11-12 Note: Immunovaccine said it received conditional approval to transfer its listing to the Toronto Stock …

    Published on 11/17/2014
  • MacroGenics financial update

    MacroGenics Inc. (NASDAQ:MGNX), Rockville, Md. Business: Cancer, Autoimmune, Antibodies Date announced: 2014-11-12 Note: MacroGenics filed a shelf registration covering the sale of up to $150 million of its securities. …

    Published on 11/17/2014
  • Pernix Therapeutics financial update

    Pernix Therapeutics Holdings Inc. (NASDAQ:PTX), Morristown, N.J. Business: Infectious Date announced: 2014-11-07 Note: Pernix filed a shelf registration covering the sale of up to $300 million of its securities. The …

    Published on 11/17/2014
  • Probiodrug financial update

    Probiodrug AG (Euronext:PBD), Halle/Saale, Germany Business: Neurology, Autoimmune, Inflammation Date announced: 2014-11-13 Note: Probiodrug raised EUR744,139 ($928,090) through the sale of 48,796 shares at EUR15.25 to …

    Published on 11/17/2014
  • Syngen Biotech financial update

    Syngen Biotech Co. Ltd. (GreTai-E:8279), Tainan, Taiwan Business: Generics, Nutraceuticals, Agbio/Environmental Date announced: 2014-11-14 Note: Syngen began the formal process to list on the GreTai Securities Market in…

    Published on 11/17/2014
  • VG Life Sciences financial update

    VG Life Sciences Inc. (OTCQB:VGLS), San Marino, Calif. Business: Infectious Date announced: 2014-10-14 Note: VG Life Sciences said the SEC has completed its review of the company's Form 10 statement. In June, the …

    Published on 11/17/2014
  • Zogenix financial update

    Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif. Business: Neurology Date announced: 2014-11-06 Note: Zogenix filed a shelf registration covering the sale of up to $100 million of its securities. The company, which closed …

    Published on 11/17/2014
  • Oasmia proposes rights offering

    Oasmia Pharmaceutical AB (SSE:OASM A), Uppsala, Sweden Business: Cancer, Drug delivery, Veterinary Date announced: 2014-11-11 Type: Rights offering To be raised: Up to SEK176.1 million ($23.8 million) Shares: 9.8 …

    Published on 11/17/2014
  • NeuroDerm amends IPO

    NeuroDerm Ltd., Ness Ziona, Israel Business: Neurology, Drug delivery Date announced: 2014-11-03 Type: IPO To be raised: Up to $72 million Shares: 4.5 million Price: $13-$16 Underwriters: Jefferies; Cowen; Oppenheimer; …

    Published on 11/10/2014
  • PolyPid amends IPO

    PolyPid Ltd., Petach Tikva, Israel Business: Drug delivery Date announced: 2014-10-31 Type: IPO To be raised: Up to $21.8 million Shares: 1.8 million Price: $10-$12 Underwriters: Aegis Capital; MLV; Chardan Capital …

    Published on 11/10/2014
  • Coherus BioSciences completes IPO

    Coherus BioSciences Inc. (NASDAQ:CHRS), Redwood City, Calif. Business: Biosimilars Date completed: 2014-11-06 Type: IPO Raised: $85 million Shares: 6.3 million Price: $13.50 Shares after offering: 32.1 million …

    Published on 11/10/2014
  • CTI BioPharma completes private placement of convertible preferred stock

    CTI BioPharma Corp. (NASDAQ:CTIC; Milan:CTIC), Seattle, Wash. Business: Cancer, Hematology, Autoimmune Date completed: 2014-11-07 Type: Private placement of convertible preferred stock Raised: $35 million Shares: 35,000…

    Published on 11/10/2014
  • Innocrin Pharmaceuticals completes venture financing

    Innocrin Pharmaceuticals Inc., Durham, N.C. Business: Cancer Date completed: 2014-10-22 Type: Venture financing Raised: $14 million Investors: Novartis Option Fund; Lilly Ventures; Hatteras Funds; Intersouth Partners; …

    Published on 11/10/2014
  • InspireMD completes direct public offering

    InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date completed: 2014-11-04 Type: Direct public offering Raised: $8.1 million Shares: 6.3 million Price: $1.30 Shares after offering: 42.4 million …

    Published on 11/10/2014
  • Mast Therapeutics completes follow-on

    Mast Therapeutics Inc. (NYSE-M:MSTX), San Diego, Calif. Business: Cardiovascular, Hematology, Cancer Date completed: 2014-11-06 Type: Follow-on Raised: $21 million Units: 30.9 million Price: $0.48 (unit) Shares after …

    Published on 11/10/2014
  • MDxHealth completes private placement

    MDxHealth S.A. (Euronext:MDXH), Liege, Belgium Business: Diagnostic Date completed: 2014-11-05 Type: Private placement Raised: EUR12.3 million ($15.4 million) Shares: 3.4 million Price: EUR3.60 Shares after offering: 37…

    Published on 11/10/2014
  • Molecular Partners completes IPO

    Molecular Partners AG (SIX:MOLN), Schlieren, Switzerland Business: Ophthalmic, Cancer, Inflammation Date completed: 2014-11-04 Type: IPO Raised: CHF96.5 million ($100 million) Shares: 4.4 million Price: CHF22.40 Shares …

    Published on 11/10/2014
  • Prostate Management Diagnostics completes venture financing

    Prostate Management Diagnostics Inc., St. Louis, Mo. Business: Diagnostic Date completed: 2014-11-06 Type: Venture financing Raised: $1.1 million Investors: Peter Michael Foundation; individual investors

    Published on 11/10/2014
  • Sentinext Therapeutics completes venture financing

    Sentinext Therapeutics Sdn Bhd, Penang, Malaysia Business: Infectious Date completed: 2014-11-06 Type: Venture financing Raised: $14 million Investors: Malaysia Venture Capital; Agensi Inovasi Malaysia; Malaysian Life …

    Published on 11/10/2014
  • Xenon completes IPO

    Xenon Pharmaceuticals Inc. (NASDAQ:XENE), Burnaby, B.C. Business: Pharmacogenetics, Neurology, Endocrine/Metabolic Date completed: 2014-11-05 Type: IPO Raised: $36 million Shares: 4 million Price: $9 Shares after …

    Published on 11/10/2014
  • Xenon completes private placement

    Xenon Pharmaceuticals Inc. (NASDAQ:XENE), Burnaby, B.C. Business: Pharmacogenetics, Neurology, Endocrine/Metabolic Date completed: 2014-11-05 Type: Private placement Raised: $4.5 million Shares: 495,000 Price: $9 Shares…

    Published on 11/10/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993